1 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 50 of 1070 | 2990 prescriptions Less than 1% of all prescriptions | 2030 | 630 patients 18% of all patients | 430 patients 12% of all patients | |
2 MONTELUKAST SODIUM | 200 of 1030 | 1720 prescriptions Less than 1% of all prescriptions | 1170 | 430 patients 12% of all patients | 320 patients 9% of all patients | |
3 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 240 of 1200 | 1790 prescriptions Less than 1% of all prescriptions | 1410 | 460 patients 13% of all patients | 350 patients 10% of all patients | |
4 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 260 of 1240 | 1690 prescriptions Less than 1% of all prescriptions | 1350 | 390 patients 11% of all patients | < 11 | |
5 FLUTICASONE PROPIONATE | 90 of 1080 | 1580 prescriptions Less than 1% of all prescriptions | 1310 | 580 patients 17% of all patients | 470 patients 13% of all patients | |
6 SPIRIVA (TIOTROPIUM BROMIDE) | 330 of 1240 | 1100 prescriptions Less than 1% of all prescriptions | 660 | 280 patients 8% of all patients | < 11 | |
7 PREDNISONE | 310 of 1230 | 1490 prescriptions Less than 1% of all prescriptions | 1190 | 690 patients 20% of all patients | 550 patients 16% of all patients | |
8 PROAIR HFA (ALBUTEROL SULFATE) | 250 of 1130 | 1230 prescriptions Less than 1% of all prescriptions | 940 | 630 patients 18% of all patients | 460 patients 13% of all patients | |
9 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 170 of 770 | 830 prescriptions Less than 1% of all prescriptions | 700 | 220 patients 6% of all patients | < 11 | |
10 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 230 of 1050 | 920 prescriptions Less than 1% of all prescriptions | | 180 patients 5% of all patients | < 11 | |
11 VENTOLIN HFA (ALBUTEROL SULFATE) | 360 of 1220 | 960 prescriptions Less than 1% of all prescriptions | 630 | 350 patients 10% of all patients | < 11 | |
12 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 190 of 760 | 530 prescriptions Less than 1% of all prescriptions | | 130 patients 4% of all patients | < 11 | |
13 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 420 of 990 | 490 prescriptions Less than 1% of all prescriptions | 360 | 140 patients 4% of all patients | < 11 | |
14 AZITHROMYCIN | 270 of 1100 | 800 prescriptions Less than 1% of all prescriptions | 590 | 430 patients 12% of all patients | < 11 | A |
15 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 140 of 500 | 530 prescriptions Less than 1% of all prescriptions | | 130 patients 4% of all patients | < 11 | |
16 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 180 of 550 | 350 prescriptions Less than 1% of all prescriptions | 210 | 140 patients 4% of all patients | < 11 | |
17 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 160 of 420 | 300 prescriptions Less than 1% of all prescriptions | 300 | < 11 | < 11 | |
18 FLOVENT HFA (FLUTICASONE PROPIONATE) | 270 of 810 | 300 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 130 of 360 | 300 prescriptions Less than 1% of all prescriptions | | 120 patients 3% of all patients | < 11 | |
20 ESBRIET (PIRFENIDONE) | 90 of 350 | 260 prescriptions Less than 1% of all prescriptions | 260 | < 11 | < 11 | |
21 OMEPRAZOLE | 250 of 580 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 DULERA (MOMETASONE/FORMOTEROL) | 170 of 490 | 230 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
23 DALIRESP (ROFLUMILAST) | 350 of 560 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
24 FUROSEMIDE | 270 of 420 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 ETHAMBUTOL HCL | 110 of 150 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 PANTOPRAZOLE SODIUM | 230 of 360 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
27 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 100 of 270 | 230 prescriptions Less than 1% of all prescriptions | | 210 patients 6% of all patients | < 11 | A |
28 DOXYCYCLINE HYCLATE | 90 of 260 | 210 prescriptions Less than 1% of all prescriptions | | 180 patients 5% of all patients | < 11 | A |